Menu
GeneBe

RGS10

regulator of G protein signaling 10, the group of Regulators of G-protein signaling

Basic information

Region (hg38): 10:119499816-119542719

Links

ENSG00000148908NCBI:6001OMIM:602856HGNC:9992Uniprot:O43665AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RGS10 gene.

  • Inborn genetic diseases (4 variants)
  • not specified (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RGS10 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
4
clinvar
4
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 0 4 0 1

Variants in RGS10

This is a list of pathogenic ClinVar variants found in the RGS10 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-119500117-G-A not specified Uncertain significance (Sep 16, 2021)2249962
10-119500160-C-T not specified Uncertain significance (Jun 16, 2023)2603990
10-119500243-T-C not specified Uncertain significance (Aug 14, 2023)2592065
10-119515586-C-T not specified Uncertain significance (Feb 06, 2023)2481395
10-119526085-C-T not specified Uncertain significance (Nov 09, 2023)3153760
10-119527403-C-G not specified Uncertain significance (Jan 03, 2024)3153761
10-119527507-G-A not specified Benign (Jan 24, 2024)2688104

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RGS10protein_codingprotein_codingENST00000369103 542881
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.7590.239125740051257450.0000199
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.335995.70.6160.000005151217
Missense in Polyphen1336.5180.35599435
Synonymous0.9743037.60.7980.00000231301
Loss of Function2.4819.050.1104.66e-7111

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006150.0000615
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00002730.0000264
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Regulates G protein-coupled receptor signaling cascades, including signaling downstream of the muscarinic acetylcholine receptor CHRM2. Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound form (PubMed:8774883, PubMed:10608901, PubMed:9353196, PubMed:11443111, PubMed:18434541). Modulates the activity of potassium channels that are activated in response to CHRM2 signaling (PubMed:11443111). Activity on GNAZ is inhibited by palmitoylation of the G-protein (PubMed:9353196). {ECO:0000269|PubMed:10608901, ECO:0000269|PubMed:11443111, ECO:0000269|PubMed:18434541, ECO:0000269|PubMed:8774883, ECO:0000269|PubMed:9353196}.;
Pathway
Mesodermal Commitment Pathway;Myometrial Relaxation and Contraction Pathways;Calcium Regulation in the Cardiac Cell;Signaling by GPCR;Signal Transduction;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;G alpha (i) signalling events;GPCR signaling-G alpha i;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.142

Intolerance Scores

loftool
0.435
rvis_EVS
-0.08
rvis_percentile_EVS
47.79

Haploinsufficiency Scores

pHI
0.156
hipred
Y
hipred_score
0.800
ghis
0.628

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.813

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Rgs10
Phenotype
cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; skeleton phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype;

Gene ontology

Biological process
response to amphetamine;G protein-coupled acetylcholine receptor signaling pathway;regulation of G protein-coupled receptor signaling pathway;negative regulation of signal transduction;positive regulation of GTPase activity
Cellular component
nucleus;cytosol;neuronal cell body;dendritic spine;axon terminus
Molecular function
G-protein alpha-subunit binding;GTPase activator activity